- Home
- SOND vs CASI Comparison
SOND vs CASI Comparison
Compare SOND & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- CASI
- Stock Information
- Founded
- SOND 2014
- CASI 1991
- Country
- SOND United States
- CASI China
- Employees
- SOND N/A
- CASI N/A
- Industry
- SOND Hotels/Resorts
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- CASI Health Care
- Exchange
- SOND Nasdaq
- CASI Nasdaq
- Market Cap
- SOND 23.2M
- CASI 20.5M
- IPO Year
- SOND N/A
- CASI 1996
- Fundamental
- Price
- SOND $3.00
- CASI $1.40
- Analyst Decision
- SOND
- CASI Strong Buy
- Analyst Count
- SOND 0
- CASI 1
- Target Price
- SOND N/A
- CASI $4.00
- AVG Volume (30 Days)
- SOND 328.4K
- CASI 313.5K
- Earning Date
- SOND 07-22-2025
- CASI 08-15-2025
- Dividend Yield
- SOND N/A
- CASI N/A
- EPS Growth
- SOND N/A
- CASI N/A
- EPS
- SOND N/A
- CASI N/A
- Revenue
- SOND $624,458,000.00
- CASI $31,368,000.00
- Revenue This Year
- SOND $28.50
- CASI N/A
- Revenue Next Year
- SOND $17.62
- CASI N/A
- P/E Ratio
- SOND N/A
- CASI N/A
- Revenue Growth
- SOND 8.32
- CASI 8.39
- 52 Week Low
- SOND $0.88
- CASI $1.09
- 52 Week High
- SOND $10.50
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- SOND 65.52
- CASI 44.81
- Support Level
- SOND $2.69
- CASI $1.23
- Resistance Level
- SOND $3.44
- CASI $1.50
- Average True Range (ATR)
- SOND 0.35
- CASI 0.12
- MACD
- SOND 0.10
- CASI 0.03
- Stochastic Oscillator
- SOND 79.64
- CASI 78.05
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.